³ÉÈËVRÊÓƵ

S'abonner à flux HBHL Stories Feed
±«¸é³¢Ìý: /hbhl/taxonomy/term/84/all
Mis à jourÌý: il y a 1 jour 34 min

Cultivating Indigenous Knowledge and Community at ³ÉÈËVRÊÓƵ

mar, 11/19/2024 - 16:37
<p>After three years, ³ÉÈËVRÊÓƵ’s <a href="/branches/programs/impress">Indigenous Mentorship and Paid Research Experience for Summer Students (IMPRESS)</a> program continues to empower Indigenous students to overcome barriers and flourish in their academic pursuits, all while supporting Indigenous perspectives and knowledge at ³ÉÈËVRÊÓƵ.Ìý</p>

Explore, Connect, Lead: Opportunities with the HBHL Trainee Committee

jeu, 08/29/2024 - 15:17
<p>Are you passionate about neuroscience and eager to get involved in the ³ÉÈËVRÊÓƵ community? The Healthy Brains, Healthy Lives (HBHL) Trainee Committee offers graduate students and postdoctoral fellows the chance to connect with like-minded peers and develop professionally by being part of a team that facilitates monthly networking events, academic talks and helps organize HBHL’s annual Symposium. Since 2017, over 80 graduate students and postdoctoral fellows have participated in the Trainee Committee.</p>

The BigBrain: Mapping the Future of Neuroscience

mer, 07/03/2024 - 10:27
<p>A decade after Alan Evans and Katrin Amunts made waves in the neuroscience world with the BigBrain,Ìý<a href="https://www.science.org/doi/10.1126/science.1235381">unveiled in Science in 2013</a>, they are working to take their original model to the next level.</p>

Developing gene therapy for Ataxia of Charlevoix-Saguenay

mer, 07/03/2024 - 10:22
<p>Research at ³ÉÈËVRÊÓƵ has brought promising developments in gene therapy targeting a rare hereditary disease present in Quebec.</p>

Charting a Safer Course: Advancements in Chronic Pain Treatment

lun, 04/08/2024 - 11:00
<p>Chronic pain affects one in every five individuals, yet effective treatment options are far and few between. Too often, chronic pain patients are left to choose between opioids, anticonvulsants for nerve pain and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, all of which present their own negative side effects.</p>

Brains on a Dish: Revolutionizing Parkinson’s Disease research with brain organoids

lun, 02/19/2024 - 16:56
<p>Parkinson’s Disease (PD) affects nearly 100,000 Canadians and 10 million people worldwide. Characterized by a dopamine deficiency in the brain, this neurodegenerative disease disrupts signal transmission in the brain, impacting its proper functioning. Motor symptoms, like tremors, slowness of movement and imbalance problems can appear and deteriorate in patients who have quietly carried the disease for years. Equally devastating are PD’s lesser-known symptoms, like depression, anxiety, hallucinations, dizziness and sleep disorders.</p>

Four Questions for Professor Alan C. Evans

jeu, 06/20/2019 - 11:51
Dr. Alan Evans was recently honoured with the 2019 Glass Brain award for pioneering work in neuroimaging, the technologies we rely on to navigate the human brain.

Dr. Guy Rouleau receives award

mer, 06/19/2019 - 20:45
Dr. Guy Rouleau recognized for outstanding contributions in the field of neuropsychopharmacology

Annual HBHL scientific events highlight outstanding neuroscience research at ³ÉÈËVRÊÓƵ

lun, 06/10/2019 - 13:37
HBHL brought ³ÉÈËVRÊÓƵ's neuroscience community together for two days of thoughtful discussion and exchange.

Helping people see again

mar, 06/04/2019 - 16:39
HBHL-supported researcher Christopher Pack examines how the brain sees the world

Le NeuroÌý³ÉÈËVRÊÓƵ

Ìý

Le Neuro (L'Institut-Hôpital neurologiqueÌýde Montréal) - un institut de recherche et d’enseignement bilingue de ³ÉÈËVRÊÓƵ, qui offre des soins de haut calibre aux patients - est la pierre angulaire de la Mission en neurosciences du Centre universitaire de santé ³ÉÈËVRÊÓƵ. Nous sommes fiers d’être une institution Killam, soutenue par les fiducies Killam.

Ìý

Ìý

Back to top